Article
Fingolimod alters intrathecal B cell maturation in multiple sclerosis patients
2020-04-20
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: B cells are postulated to play multiple roles in the pathogenesis of multiple sclerosis (MS) including pathogenic antibody production, antigen-presentation and pro-inflammatory cytokine secretion. Natalizumab and fingolimod are effective MS therapies that disrupt lymphocyte migration but exert differential effects on B cell maturation and trafficking. Herein, we...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f02bf5ca-edfb-54b5-97d6-e0f795c0351b
- DOI
- 10.21203/rs.3.rs-23388/v1
